Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,676 | 38,485 | 35,075 | 42,454 | 30,432 |
| Marketable Securities | 187,549 | 190,202 | 214,645 | 189,019 | 73,143 |
| Receivables | 17,118 | 11,539 | 11,395 | 9,060 | 11,996 |
| Inventories | 21,722 | 20,373 | 17,323 | 15,730 | 13,320 |
| TOTAL | $267,905 | $270,026 | $286,075 | $261,915 | $132,923 |
| Non-Current Assets | |||||
| PPE Net | 8,600 | 7,385 | 6,465 | 5,515 | 4,776 |
| Investments And Advances | 45,431 | 45,328 | 31,149 | 64,004 | 0 |
| Other Non-Current Assets | 6,807 | 7,307 | 6,282 | 6,590 | 11,946 |
| TOTAL | $60,838 | $60,020 | $43,896 | $76,109 | $16,722 |
| Total Assets | $328,743 | $330,046 | $329,971 | $338,024 | $149,645 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,998 | 4,461 | 3,424 | 3,454 | 2,852 |
| Accrued Expenses | 22,431 | 17,605 | 13,405 | 10,565 | 15,828 |
| TOTAL | $30,924 | $25,388 | $19,489 | $16,492 | $21,148 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,557 | 1,342 | 1,141 | 949 | 939 |
| Other Non-Current Liabilities | 6,912 | 6,912 | 6,179 | 5,450 | 371,997 |
| TOTAL | $10,209 | $9,898 | $8,849 | $7,780 | $373,857 |
| Total Liabilities | $41,133 | $35,286 | $28,338 | $24,272 | $395,005 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,382 | 44,025 | 43,470 | 43,356 | N/A |
| Common Shares | 4 | 4 | 4 | 4 | 1 |
| Retained earnings | -369,937 | -356,471 | -342,262 | -325,393 | -296,737 |
| Other shareholders' equity | 403 | 354 | 149 | 240 | 65 |
| TOTAL | $287,610 | $294,760 | $301,633 | $313,752 | $-245,360 |
| Total Liabilities And Equity | $328,743 | $330,046 | $329,971 | $338,024 | $149,645 |